Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Lauffer

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Allergy|August 28, 2025
Skin Lipid-Microbe Interplay Links Staphylococcus hominis to Barrier Control in Adult Atopic DermatitisMadhumita Bhattacharyya, Felix Lauffer, Manja Jargosch, et al.
Experimental Dermatology|May 20, 2016
A novel molecular disease classifier for psoriasis and eczemaNatalie Garzorz-Stark, Linda Krause, Felix Lauffer, et al.
The Journal of Allergy and Clinical Immunology|November 13, 2025
Neutralizing IL-22RA1 improves histologic and molecular alterations associated with atopic dermatitis pathogenesisSophia Wasserer, Thomas Litman, Josephine Hebsgaard, et al.
The Journal of Investigative Dermatology|February 24, 2018
Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic DermatitisNick Vandeghinste, Jürgen Klattig, Catherine Jagerschmidt, et al.
Science Translational Medicine|February 15, 2023
IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseasesStéphanie Lavazais, Manja Jargosch, Sonia Dupont, et al.
The Journal of Allergy and Clinical Immunology|September 23, 2017
Toll-like receptor 7/8 agonists stimulate plasmacytoid dendritic cells to initiate T<sub>H</sub>17-deviated acute contact dermatitis in human subjectsNatalie Garzorz-Stark, Felix Lauffer, Linda Krause, et al.
JAMA Dermatology|July 31, 2024
Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis: The GUIDE Randomized Clinical TrialKilian Eyerich, Khusru Asadullah, Andreas Pinter, et al.
The Journal of Investigative Dermatology|March 8, 2023
Gene Expression-Based Molecular Test as Diagnostic Aid for the Differential Diagnosis of Psoriasis and Eczema in Formalin-Fixed and Paraffin-Embedded Tissue, Microbiopsies, and Tape StripsFelix Fischer, Anais Doll, Deniz Uereyener, et al.
Science Advances|October 22, 2025
Immunopeptidome analysis reveals SERPINB3 as an autoantigen driving eczematized psoriasisManja Jargosch, Jomy Kuruvila, Emanuele Scala, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Allergy|August 28, 2025
Skin Lipid-Microbe Interplay Links Staphylococcus hominis to Barrier Control in Adult Atopic DermatitisMadhumita Bhattacharyya, Felix Lauffer, Manja Jargosch, et al.
Experimental Dermatology|May 20, 2016
A novel molecular disease classifier for psoriasis and eczemaNatalie Garzorz-Stark, Linda Krause, Felix Lauffer, et al.
The Journal of Allergy and Clinical Immunology|November 13, 2025
Neutralizing IL-22RA1 improves histologic and molecular alterations associated with atopic dermatitis pathogenesisSophia Wasserer, Thomas Litman, Josephine Hebsgaard, et al.
The Journal of Investigative Dermatology|February 24, 2018
Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic DermatitisNick Vandeghinste, Jürgen Klattig, Catherine Jagerschmidt, et al.
Science Translational Medicine|February 15, 2023
IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseasesStéphanie Lavazais, Manja Jargosch, Sonia Dupont, et al.
The Journal of Allergy and Clinical Immunology|September 23, 2017
Toll-like receptor 7/8 agonists stimulate plasmacytoid dendritic cells to initiate T<sub>H</sub>17-deviated acute contact dermatitis in human subjectsNatalie Garzorz-Stark, Felix Lauffer, Linda Krause, et al.
JAMA Dermatology|July 31, 2024
Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis: The GUIDE Randomized Clinical TrialKilian Eyerich, Khusru Asadullah, Andreas Pinter, et al.
The Journal of Investigative Dermatology|March 8, 2023
Gene Expression-Based Molecular Test as Diagnostic Aid for the Differential Diagnosis of Psoriasis and Eczema in Formalin-Fixed and Paraffin-Embedded Tissue, Microbiopsies, and Tape StripsFelix Fischer, Anais Doll, Deniz Uereyener, et al.
Science Advances|October 22, 2025
Immunopeptidome analysis reveals SERPINB3 as an autoantigen driving eczematized psoriasisManja Jargosch, Jomy Kuruvila, Emanuele Scala, et al.
Pageof 4